Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
RedHill will receive $500,000 in guaranteed payments, including a $250,000 upfront payment and $250,000 in fixed payments due within 18 months
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
A new weapon in the global fight against malaria
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
Subscribe To Our Newsletter & Stay Updated
